Welcome to Scop3P

Search for the desired protein with Uniprot accession, protein name/keyword, ProteomeXchange ID or PDB id

Ex.: O00571, ddx3x (keyword), ATP-dependent RNA helicase DDX3X, PXD000680 or 3JRV

  • Zoom in and zoom out (both with mouse and buttons on the right top corner) to see modificationson the protein
  • Slide the chart to see other modifications (both with mouse and buttons on the right topcorner)
  • Hover on the modification to see more information and position on the structure.
PDB 
 AlphaFold
Phospho-sites

Showing 3 results

Swiss-Prot Position Modification Source Evidence Singly phosphorylated
562 SER PRIDE yes
598 SER PRIDE
606 THR PRIDE

3D structure is not available

Display Settings

Hover over to see the values, zoom (in/out) or drag by using the mouse pointer.

Phosphorylated amino acids are colored red on the inner ring.

The first amino acid of the protein sequence is colored darker on each ring.

Phospho peptides

Showing 4 results

Sequence Modified position (Swiss-Prot) Peptide start Peptide end Modified position (Peptide) Number of projects
562 556 566 7 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD001550 2 Human CRC cell line baseline phosphoproteomics Homo sapiens (Human) PARTIAL 2015-04-15 cell culture
598 596 602 3 2
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD000612 5 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
PXD002286 1 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 - -
598 596 613 3 3
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD000612 2 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD002286 1 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 - -
PXD000680 5 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell
606 596 613 11 3
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI 
PXD000612 2 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD002286 1 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 -
PXD000680 5 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell -

Structures

Showing 0 results

PDB id Chain Method Resolution Stoichiometry Interfacing Molecule/Chain Complex Formation Significance Score (CSS) P-sites View Structure

Mutations

Showing 53 results

Swiss-Prot Position Amino acid (Wild type) Amino acid (Variant) Variant Type Disease
10 R W Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
27 G R Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
86 S R Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
112 C F Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
198 P L Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
211 P L Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
241 P R Polymorphism
257 A D Polymorphism
266 R W Polymorphism
290 R G Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
305 R W Polymorphism
334 A V Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
336 A V Polymorphism
350 V M Polymorphism
368 A V Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
370 I T Polymorphism
385 F I Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
387 T M Polymorphism
394 M I Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
395 M L Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
404 T M Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
419 R W Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
440 L F Polymorphism
443 V I Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
446 M V Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
473 I S Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
476 N D Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
481 A T Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
489 N D Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
519 V A Polymorphism
549 H Q Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
560 R H Polymorphism
592 T I Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
614 K N Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
615 H R Polymorphism
617 I L Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
633 V I Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
652 W R Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
678 E K Unclassified
679 W C Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
684 F C Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
688 L F Unclassified
720 R C Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
722 I T Polymorphism
724 A P Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
736 S L Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
743 P L Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
773 A T Unclassified A breast cancer sample
775 G R Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
787 A V Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
795 G R Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
799 Q H Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]
827 Y H Disease Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]